Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP science

Jean-Michel Molina, MD, on Biomedical Failures of PrEP: Rare, But Serious

Editor's pick
Contagion Live
14 March 2019
Government, leadership & policy

Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Editor's pick
The New York Times
14 March 2019
PrEP policies & guidelines

Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Editor's pick
FiercePharma
14 March 2019
PrEP science

TAF: Quick-dissolve combination PrEP insert is effective against HIV infections in monkeys; intermittent solo pill less so

News
13 March 2019
PrEP programmes & uptake

Young Black Men at Risk for HIV Underestimate Threat

Editor's pick
Medscape (requires free registration)
12 March 2019
PrEP policies & guidelines

Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

Editor's pick
Evening Standard
12 March 2019
PrEP policies & guidelines

How Many More Must Needlessly Contract HIV Before We Ensure Proper Access To PrEP?

Editor's pick
Huffington Post
12 March 2019
PrEP science

Effective HIV Interventions Have Changed the Approach to Trials

Editor's pick
Infectious Diseases Consultant
11 March 2019
PrEP programmes & uptake

People stay on PrEP for 14 months on average in the US, study finds

News
10 March 2019
PrEP programmes & uptake

PrEP use jumps to 35 percent among gay and bi men at risk of HIV

Editor's pick
NBCNews.com
8 March 2019
PrEP science

How many people who have used PrEP get HIV the same year? New York study finds out

News
7 March 2019
PrEP science

Descovy is non-inferior to Truvada for daily PrEP

News
6 March 2019
PrEP policies & guidelines

Here's how to get onto England's PrEP trial

Editor's pick
Gay Star News
6 March 2019
Epidemiology

55% drop in HIV incidence in gay men in England in just two years

News
5 March 2019
PrEP

Should the NIH Break HIV Prevention Drug Truvada's Patent?

Editor's pick
Fortune
5 March 2019
Government, leadership & policy

Ireland: The new HIV crisis needs a better response

Editor's pick
Irish Times
4 March 2019
PrEP

Examining the Truvada #BreakThePatent Debate: Gilead Responds

Editor's pick
IPWatchdog.com
4 March 2019
PrEP policies & guidelines

SF health officials embrace non-daily PrEP dosing regimen

Editor's pick
Bay Area Reporter
28 February 2019
PrEP programmes & uptake

Councils in London may block additional PrEP places proposed for gay and bisexual men

Editor's pick
National AIDS Trust
28 February 2019
PrEP programmes & uptake

PrEP Impact Trial to be expanded

Editor's pick
NHS England
28 February 2019
PrEP programmes & uptake

Scotland's introduction of HIV drug PrEP 'puts England to shame'

Editor's pick
The Guardian
28 February 2019
PrEP programmes & uptake

Major shift in HIV war as Kenyans now top users of prevention pill

Editor's pick
The Standard
27 February 2019
PrEP programmes & uptake

Scotland: PrEP drug uptake 'exceeds predictions'

Editor's pick
BBC
27 February 2019
PrEP programmes & uptake

Implementation of HIV PrEP in Scotland: First Year Report

Editor's pick
Health Protection Scotland
27 February 2019